Hoth Therapeutics, Inc. (HOTH)

Trade HOTH now with
2/19/2020 10:52:06 AM Hoth Therapeutics Receives Notice Of Allowance From European Patent Office
2/12/2020 9:05:54 AM Hoth Announces Positive Preliminary, Preclinical Data On Therapeutic For Chronic Autoimmune Skin Disease
1/15/2020 9:25:06 AM Hoth Therapeutics Exercises Option To Take Exclusive License For Patents Owned By George Washington University
12/19/2019 7:13:23 AM Hoth Therapeutics Enters Research Collaboration Deal With Weill Cornell Medicine To Examine The Efficacy Of RAMBA
12/17/2019 11:01:06 AM Hoth Therapeutics Appoints William Weglicki To Scientific Advisory Board
12/9/2019 8:09:40 AM Hoth And North Carolina State University Initiate Preclinical Gene Therapy Study For The Treatment Of Asthma
9/4/2019 8:00:00 AM Hoth Therapeutics, Inc. Issues Letter to Shareholders (Press Release)
7/15/2019 8:26:04 AM Hoth Therapeutics Enters Exclusive License Option Agreement With The George Washington University
6/10/2019 8:02:21 AM Hoth Therapeutics To Begin Production Of BioLexa Therapeutic For Upcoming Toxicology And Clinical Trials
6/6/2019 8:09:04 AM Hoth Forms Subsidiary, Hoth Therapeutics Australia, In Anticipation To Perform Clinical Trials For Atopic Dermatitis